Get startedLog in
    Picture of Global Longlife Hospital and Research logo

    543520 — Global Longlife Hospital and Research Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Global Longlife Hospital and Research, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue3273282351355.77
    Cost of Revenue
    Gross Profit24115610050.5-16.9
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Other Operating Expenses
    Total Operating Expenses28525920615152.2
    Operating Profit41.869.428.7-15.6-46.4
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes18.257.127.1-22.70.992
    Provision for Income Taxes
    Net Income After Taxes10.435.718.3-21.91.99
    Net Income Before Extraordinary Items
    Net Income10.435.718.3-21.91.99
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income10.435.718.3-21.91.99
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS1.485.161.79-2.080.19
    Dividends per Share